Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Donn Casale currently holds 1,036,923 shares of ARS Pharmaceuticals, Inc. (SPRY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Donn Casale has been a net neutral trader of SPRY stock. They have purchased $0 and sold $0 worth of shares.
Donn Casale's most recent insider trade was on Oct 1, 2026, when they sold 1,036,923 shares at $0.00 per share.
Donn Casale serves as Executive at ARS Pharmaceuticals, Inc. (SPRY). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Donn Casale holds the position of Executive at ARS Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Donn Casale has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Donn Casale was on Oct 1, 2026, when they purchased $0 worth of SPRY shares. This transaction involved 1,036,923 shares at N/A per share.
Donn Casale currently owns 1,036,923 shares of ARS Pharmaceuticals, Inc. (SPRY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Donn Casale's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Donn Casale has 1 Form 4 filings on record as an insider at ARS Pharmaceuticals, Inc..
Set alerts for Donn Casale and 40,000+ other insiders.